SCHEMBL19013441

SCHEMBL19013441

CCCn1c(Br)nc2c1c(=O)n(Cc1ccc(Cl)c(Cl)c1)c(=O)n2C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.63
▸ TP53 P04637 2/20 0.63
▸ SMN1; SMN2 Q16637 5/20 0.62
▸ CYP1A2 P05177 2/20 0.62
▸ CYP3A4 P08684 2/20 0.62
▸ CYP2C9 P11712 2/20 0.62
▸ CYP2C19 P33261 2/20 0.62
▸ LMNA P02545 4/20 0.58
▸ STAT6 P42226 1/20 0.58
▸ ALDH1A1 P00352 5/20 0.56
▸ TSHR P16473 5/20 0.56
▸ NPSR1 Q6W5P4 4/20 0.56
▸ HPGD P15428 3/20 0.56
▸ HTT P42858 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ POLB P06746 1/20 0.55
▸ MTHFD2 P13995 1/20 0.55
▸ HIF1A Q16665 4/20 0.54
▸ PKM P14618 1/20 0.53
▸ CYP2D6 P10635 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18989627 0.89 SMN1; SMN2 (0.66) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL18989729 0.87 SMN1; SMN2 (0.60) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL18990448 0.87 SMN1; SMN2 (0.57) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL18989807 0.85 SMN1; SMN2 (0.58) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL16076170 0.84 TSHR (0.70) MAPTSMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL18989851 0.84 SMN1; SMN2 (0.68) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL19013920 0.84 SMN1; SMN2 (0.56) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL18989870 0.81 SMN1; SMN2 (0.54) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL18990106 0.80 MAPT (0.74) MAPTTP53SMN1; SMN2CYP1A2CYP3A4
SCHEMBL18990402 0.80 SMN1; SMN2 (0.66) MAPTTP53SMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106352-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-06-22 — — WO disclosed
Send feedback